Authorized a Start-up venture company by Korean Venture Capital Association

Funded by Korea Investment Partners ($2 millions)

Authorized the Industrial R&D center by Korea Industrial Technology Association

Funded by the Korean Ministry of SMEs and Startups ($0.2 millions)

the Korean Ministry of Trade, Industry & Energy ($2 millions)

Developed the novel peptide drugs for cavity and dentin hypersensitivity

Confirmed the physiologic dentin regeneration with CPNE7 in vivo

HysensBio Established

Began the Scientific research on dentin regeneration and tooth development